戻る Agenda
Value Assessment of Combinations in Oncology (or others): Questions and Steps toward Practical Solutions
Session Chair(s)
Meni Styliadou
VP Government Affairs & Public Policy, Europe & Canada
Takeda, Belgium
The panel will discuss likely solutions for allowing patients to get access to combination drugs in oncology in a fast and sustainable manner. Panellists will also describe positive developments and highlight what they see as practical ways to advance the debate on this critical matter for the treatment of oncology.
Speaker(s)
Panelist
Francis Arickx
National Institute for Health and Disability Insurance (RIZIV-INAMI), Belgium
Head of the Directorate Pharmaceutical Policy
Panelist
Fiona Carlin
Baker McKenzie, Belgium
Partner
Panelist
Michael Schroter, PHD, MBA
Viopas, Switzerland
Founding Partner
Panelist
Timothy Wilsdon, MS
Charles River Associates International, United Kingdom
Principal